GharibH, GoellnerJR. 1993. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med, 118:282–289.
2.
American Thyroid Association Guidelines Taskforce on ThyroidNodules, Differentiated ThyroidCancer, CooperDS, DohertyGM, HaugenBR, KloosRT, LeeSL, MandelSJ, MazzaferriEL, McIverB, PaciniF, SchlumbergerM, ShermanSI, StewardDL, TuttleRM. 2009. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid, 19:1167–1214.
GuanH, ToraldoG, CerdaS, GodleyF, RaoS, McAnenyD, DohertyG, BravermanL, LeeS. 2020. Utilities of RAS mutations in pre-operative fine needle biopsies for decision-making for thyroid nodule management: results from a single-center prospective cohort. Thyroid, 30:536–547.
5.
Patel KNYL, LubitzCC, GrubbsEG, MillerBS, ShenW, AngelosP, ChenH, DohertyGM, FaheyTJ, KebebewE, LivolsiVA, PerrierND, SiposJA, SosaJA, StewardD, TufanoRP, McHenryCR, CartySE. 2020. The American Association of Endocrine Surgeons Guidelines for the definitive surgical management of thyroid disease in adults. Ann Surg, 271:e21–e93.
6.
NikiforovYE, SeethalaRR, TalliniG, BalochZW, BasoloF, ThompsonLD, BarlettaJA, WenigBM, Al GhuzlanA, KakudoK, GiordanoTJ, AlvesVA, KhanafsharE, AsaSL, El-NaggarAK, GoodingWE, HodakSP, LloydRV, MaytalG, MeteO, NikiforovaMN, NoseV, PapottiM, PollerDN, SadowPM, TischlerAS, TuttleRM, WallKB, LiVolsiVA, RandolphGW, GhosseinRA. 2016. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol, 2:1023–1029.
7.
YipL, NikiforovaMN, YooJY, McCoyKL, StangMT, ArmstrongMJ, NicholsonKJ, OhoriNP, CoyneC, HodakSP, FerrisRL, LeBeauSO, NikiforovYE, CartySE. 2015. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients. Ann Surg, 262:519–525; discussion 524–525.
8.
XingM, LiuR, LiuX, MuruganAK, ZhuG, ZeigerMA, PaiS, BishopJ. 2014. BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol, 32:2718–2726.
